Usefulness of C-reactive protein as an independent predictor of death in patients with ischemic cardiomyopathy

Julio A. Chirinos, Juan P. Zambrano, Simon C Chakko, Alan H Schob, Anila Veerani, Guido O. Perez, Armando J. Mendez

Research output: Contribution to journalArticlepeer-review

33 Scopus citations

Abstract

The usefulness of serum C-reactive protein, an inflammatory marker, to predict mortality risk in patients who have ischemic cardiomyopathy was investigated. C-reactive protein was measured in 123 men who underwent cardiac catheterization and were noted to have left ventricular ejection fraction ≤45% and significant angiographic coronary artery disease. They were prospectively followed for 3 years. Higher levels of C-reactive protein were associated with increased mortality rate. This correlation was independent of other prognostic factors, such as age, ejection fraction, symptoms of severe congestive heart failure, use of angiotensin-converting enzyme inhibitors, and use of β blockers.

Original languageEnglish (US)
Pages (from-to)88-90
Number of pages3
JournalAmerican Journal of Cardiology
Volume95
Issue number1
DOIs
StatePublished - Jan 1 2005

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Fingerprint Dive into the research topics of 'Usefulness of C-reactive protein as an independent predictor of death in patients with ischemic cardiomyopathy'. Together they form a unique fingerprint.

Cite this